On-line Identification of the Constituents of Buyang Huanwu Decoction in Pig Serum Using Combined HPLC–DAD–MS Techniques

DH Yang,SQ Cai,HY Liu,XX Guo,CL Li,MY Shang,X Wang,YY Zhao
DOI: https://doi.org/10.1016/j.jchromb.2005.12.032
IF: 3.318
2006-01-01
Journal of Chromatography B
Abstract:Buyang Huanwu decoction (BYHWD) is a widely used Chinese traditional compound medicine that has proved effective in treating cerebrovascular illnesses; however, its active substances have remained unknown. In this paper, serum chemistry and combined high-performance liquid chromatography (HPLC), photodiode-array detection and mass-spectrometry techniques were used to study the constituents of BYHWD from pig serum after oral administration. A total of 45 characteristic HPLC peaks were detected from serum containing drug. The chemical structures of nine of the peaks were tentatively elucidated as 7,3′-dihydroxy-4′-methoxyisoflavone-7-O-glucuronide (P1), 7-hydroxy-4′-methoxyisoflavone-7-O-glucuronide (P2), 7,2′,4′-trihydroxy-3′-methoxyisoflavane-7-O-sulphate (P3), 3-hydroxy-9,10-dimethoxypterocarpan-3-O-glucuronide (P4), 7,2′-dihydroxy-3′,4′-dimethoxyisoflavane-7-O-glucuronide (P5), 3-hydroxy-9,10-dimethoxypterocarpane-3-O-sulphate (P6), 4(1H)-quinolinone (P7 or P8), 4-hydroxyquinoline (P8 or P7) and oleic acid (P9). All of the identified peaks, with the exception of P9, were metabolites of the constituents of BYHWD in vivo.
What problem does this paper attempt to address?